ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $31,000 | -84.5% | 14,076 | -75.4% | 0.00% | -75.0% |
| Q2 2021 | $200,000 | -71.2% | 57,180 | -10.7% | 0.00% | -69.2% |
| Q4 2020 | $694,000 | +19.4% | 64,000 | +13.5% | 0.01% | -23.5% |
| Q3 2020 | $581,000 | -0.3% | 56,399 | +102.1% | 0.02% | -39.3% |
| Q2 2020 | $583,000 | – | 27,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |